ArticleCureus2025
Effects of Deep Sedation With Dexmedetomidine Versus Remifentanil on Postoperative Recovery in Soft Tissue Surgery.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Soft tissue surgery comprises short or medium-duration surgical procedures, with anesthesia consisting of analgesia and sedation. Various quantitative and qualitative recovery scales are used to evaluate the quality of postoperative recovery. The primary objective of this study was to compare the effects of dexmedetomidine versus remifentanil on postoperative recovery using the Quality of Recovery-15 (QoR-15) scale to assess recovery quality in soft tissue surgeries. Methodology This prospective randomized study was conducted at the Clinic of Anesthesia, Reanimation and Intensive Care and University Clinic of Reconstructive and Plastic Surgery, Skopje, Republic of North Macedonia, involving 80 patients. Patients were randomly assigned into two groups, namely, Group 1, sedated with intraoperative dexmedetomidine infusion (Dex, n = 40), and Group 2, sedated with intraoperative remifentanil infusion (Rem, n = 40). Intraoperatively, hemodynamic and respiratory parameters were measured. Preoperatively and postoperatively, levels of leukocytes, blood sugar, and the QoR-15 score were determined. Postoperative mean arterial pressure (MAP), postoperative pain (Visual Analog Scale), and sedation level (Richmond Agitation-Sedation Scale) were compared with the quality of postoperative recovery scores (QoR-15) using Pearson's correlation coefficient. Results The results indicated that dexmedetomidine provided prolonged postoperative sedation and analgesia, which dissipated shortly thereafter, while patients sedated with remifentanil experienced pain immediately upon awakening and required more analgesics. The correlation analysis showed a negative relationship between the degree of postoperative pain and sedation and the quality of recovery. Conclusions Dexmedetomidine demonstrated a superior performance compared to remifentanil. Hence, dexmedetomidine in soft tissue surgery ensures hemodynamic stability, shows protective anti-inflammatory and anti-stress effects, provides good postoperative analgesic effects, reduces recovery time, and protects the body from undesirable postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.